Search this Site
Terbinafine News
Australian regulators issue warning on Novartis' Lamisil
Australia's drug and medical device regulatory agency, the Therapeutic Goods Administration (TGA), has issued a warning concerning nail fungus treatment Lamisil (terbinafine) tablets following reports of three deaths and severe...
Anti-fungal tablet linked to liver deaths
Three people have died and several others have suffered serious liver reactions after taking a popular tablet to treat fungal infections.
NexMed Announces Presentation of Data at the 66th Annual Meeting of the American Academy of Dermatology
NexMed, Inc., a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, today announced the presentation of data on NM100060, a topical onychomycosis (nail fungus) investigative...
FDA Approves Terbinafine (Lamisil) Granules for Tinia Capitis in Kids
The FDA has approved terbinafine oral granules (Lamisil), which can be sprinkled on food, for tinia capitis in children four years and older.
Ivrea Pharmaceuticals Announces Successful In Vitro Nail Penetration Results with IVR 101 and IVR 102
Ivrea Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company focused on developing and commercializing novel treatments for dermatologic conditions, announced today that its proprietary gels, IVR 101 and IVR...